Current Appointments & Affiliations
Adjunct Professor in the Department of Dermatology
·
2021 - Present
Dermatology,
Clinical Science Departments
Recent Publications
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis.
Journal Article J Dermatolog Treat · December 2025 BACKGROUND: Lebrikizumab monotherapy significantly improved signs and symptoms in patients with moderate-to-severe atopic dermatitis (AD) in phase 3 Advocate1 and ADvocate2 studies. OBJECTIVE: To evaluate improvements in patient-reported symptoms and quali ... Full text Link to item CiteLebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis.
Journal Article J Dermatolog Treat · December 2025 PURPOSE OF THE STUDY: Head, neck (HN), and face involvement in atopic dermatitis (AD) poses a major psychological burden and can be challenging to effectively treat. New appearance of HN dermatitis has been reported with biologics used to treat AD. Lebriki ... Full text Link to item CiteConsensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life.
Journal Article J Eur Acad Dermatol Venereol · September 2025 BACKGROUND: Hand eczema (HE) is a common and complex skin disease. A uniform set of core outcomes and related measures for use in clinical trials is lacking, making it difficult to compare results across HE studies. OBJECTIVE: To reach consensus on a set o ... Full text Link to item CiteEducation, Training & Certifications
University of Illinois ·
2002
M.D.
University of Illinois, Urbana-Champaign ·
1998
B.S.